WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
2025 Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah
Affiliated Programs
Thursday, March 13, 2025 - Friday, March 14, 2025

Sheraton Hotel 
150 West 500 South
Salt Lake City, UT

Wilson Sonsini is looking forward to the 2025 Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office. Now in its 12th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs, and the investor community.

We’re excited to have Wilson Sonsini partners featured in the Legal Track, covering key topics in licensing, investment strategies, corporate trends, and patent strategy.

Legal Track – Thursday, March 13:

  • 1:00 PM – 1:35 PM | Licensing & Collaborations – Farah Gerdes
  • 1:35 PM – 2:15 PM | Progressive Investment Strategies for IP-Backed Life Sciences Companies – Matt Bresnahan moderating panel with John Christopher LiPuma, Jess Krannich, and Bob Rogers
  • 2:30 PM – 3:00 PM | VC Life Sciences Financing Trends – Alison Johnson, Nathan Robinson, and Marc Porter
  • 3:00 PM – 3:30 PM | Patent Strategy for BioTech & TechBio – Sara Patak, Rex Watkins, and Danya Martell Smart
  • 3:30 PM – 4:00 PM | Business & Executive Advisory – Meredith Krannich and Matthew Meyer

For the full agenda and more details, visit https://eilifesciencessummit.org/agenda/.

Contacts

Kelly Cowan

kcowan@wsgr.com

Presenters

Farah B. Gerdes
Partner
Boston

Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.

View Profile
Matthew Bresnahan
Partner
San Diego

Matt is primary outside IP counsel to more than 50 life sciences companies in Southern California.

View Profile
Jess Krannich
Partner
Salt Lake City

Jess M. Krannich is a litigation partner in the Salt Lake City office of Wilson Sonsini Goodrich & Rosati. Jess is a seasoned trial lawyer who leads significant intellectual property, unfair competition, patent, and general commercial matters for a wide range of clients in the technology, life sciences, medical device, consumer products, and financial services sectors. Many of his clients are major industry leaders in the Rocky Mountain West.

View Profile
Alison G. Johnson
Partner

Alison G. Johnson is a corporate partner at Wilson Sonsini Goodrich & Rosati, where she focuses on the representation of emerging companies at all stages of growth, advising them on venture capital and other financings, mergers and acquisitions, private equity, and corporate governance matters. She also represents venture capital firms and angel investors.

View Profile
Marc Porter
Partner
Salt Lake City

Marc Porter is a corporate partner in the Salt Lake City office of Wilson Sonsini Goodrich & Rosati, where he represents innovative emerging technology, life sciences, consumer product, and other venture and private equity backed companies. He represents companies in their financings and liquidity events, as well as their day-to-day legal matters. He also has extensive experience representing companies in strategic acquisitions. Marc represents many venture capital and private equity funds in Utah and across the country. He is a trusted advisor to executives, boards of directors, entrepreneurs, and venture capital and private equity fund managers.

View Profile
Sara L. Patak
Partner
Boulder

Sara L. Patak is a partner in the Boulder office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on patent prosecution and intellectual property counseling, serving clients in a wide range of technology fields, including the pharmaceutical and biotechnology industries.

View Profile
Rex W. Watkins
Of Counsel

Rex is an experienced patent professional who has assisted life science companies, from start-ups to public companies, for more than a decade.

View Profile
Danya J. Martell Smart
Patent Agent
Boston

Dr. Danya J. Martell Smart is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where her work focuses on patents and innovations primarily in the life sciences, biotechnology, and related industries. Danya has experience in molecular biology, genomics, gene editing, next-generation sequencing, bioinformatics, protein engineering, protein biochemistry, and fluorescence microscopy.

View Profile
Meredith L. Krannich
Executive Advisor
Salt Lake City

Meredith L. Krannich is an advisor in the Executive Advisory Program of Wilson Sonsini Goodrich & Rosati. Resident in the firm’s Salt Lake City office, she focuses on leveraging her nearly 20 years of experience in the life sciences sector as a lawyer and business executive to advise clients on a variety of legal operational and business matters.

View Profile
Matthew J. Meyer
Chief Business Advisor, Life Sciences Business Advisory
San Francisco

Matthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.

View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.